Study: Inhibiting a protein could reverse leukemic stem cells

12/14/2010 | Google

U.K. scientists examined a type of leukemia caused by the faulty mixed lineage leukemia gene and found that leukemic stem cells could be converted back to a precancerous phase by inhibiting a protein in the blood. "The findings provide compelling evidence that this protein could be exploited to develop an effective therapeutic target for this form of the disease," the lead researcher said.

View Full Article in:

Google

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Corporate Counsel - Healthcare Law Group
Genentech
South San Francisco, CA